A network-based computational and experimental framework for repurposing compounds toward the treatment of non-alcoholic fatty liver disease
Danae Zareifi, Odysseas Chaliotis, Nafsika Chala, Nikolaos Meimetis, Maria Sofotasiou, Konstantinos Zeakis, Eirini Pantiora, Antonis Vezakis, George K. Matsopoulos, Georgios Fragulidis, Leonidas G. Alexopoulos
Abstract
testing.
Topics & Concepts
Drug repositioningIn silicoFatty liverSteatosisResveratrolDrug discoveryDrugComputational biologyIn vivoPharmacologyAlcoholic liver diseaseDiseaseMedicineBioinformaticsChemistryBiologyBiochemistryBiotechnologyInternal medicineGeneCirrhosisLiver Disease Diagnosis and TreatmentBioinformatics and Genomic NetworksHepatitis C virus research